Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Cutting-edge cross-linking biomaterials advancing ophthalmic therapeutics

Ning, Rui, Fu, Xueyu, Chen, Lingxin, Liu, Haochen, Huang, Xiaomin, Chen, Zhongxing, Shao, Yi, Meek, Keith M. ORCID: https://orcid.org/0000-0002-9948-7538, Hafezi, Farhad, Hillen, Mark, Tao, Wei, Zhou, Xingtao, Yang, Mei and Huang, Jinhai 2026. Cutting-edge cross-linking biomaterials advancing ophthalmic therapeutics. Progress in Retinal and Eye Research 113 , 101489. 10.1016/j.preteyeres.2026.101489

Full text not available from this repository.

Abstract

Corneal cross-linking (CXL) has emerged as an important therapeutic strategy for enhancing the biomechanical stability of corneal tissues. Originally introduced to slow or halt the progression of keratoconus (KC), its indications have expanded to include a variety of corneal ectatic and infectious disorders, alongside a growing interest in scleral reinforcement for progressive myopia. Recent advances in cross-linking technologies focused on optimizing reagent formulations, refining delivery strategies, and incorporating functional biomaterials such as nanoparticles, hydrogels, and microneedle-based systems to enhance stromal penetration, achieve controlled release, and reduce procedural invasiveness. Despite these developments, key challenges remain, particularly in achieving consistent treatment depth, maintaining long-term biosafety, and ensuring stable clinical outcomes. This review summarizes the mechanisms of action and classification of contemporary ophthalmic cross-linking methods and agents, evaluating their clinical and experimental outcomes in corneal and scleral cross-linking while weighing their respective strengths and limitations. Furthermore, this review identifies key constraints of current protocols and highlights emerging strategies aimed at improving treatment precision, safety, and reproducibility, thereby providing a conceptual framework for the development of next-generation ophthalmic cross-linking therapies.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Schools > Optometry and Vision Sciences
Publisher: Elsevier BV
ISSN: 1350-9462
Date of Acceptance: 18 June 2026
Last Modified: 13 Aug 2026 13:15
URI: https://orca.cardiff.ac.uk/id/eprint/187987

Actions (repository staff only)

Edit Item Edit Item